Protagonist therapeutics, inc. (PTGX)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Dec'15
Assets
Current assets:
Cash and cash equivalents

60,215

33,006

50,195

71,143

70,077

82,233

87,427

63,864

69,577

106,029

50,395

10,365

9,517

21,084

96,024

13,768

4,055

Marketable securities

57,298

100,011

87,497

54,958

-

46,620

-

-

-

-

-

-

-

-

-

-

-

Restricted cash - current

10

10

10

10

10

10

10

10

10

10

10

10

10

10

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

10

10

Available-for-sale securities

-

-

-

-

42,469

-

51,090

61,303

65,383

37,972

43,191

54,127

53,731

56,515

2,499

6,408

7,868

Receivable from collaboration partner and contract asset - related party

3,594

6,755

1,945

4,889

5,061

4,587

4,586

-

-

1,816

-

-

-

-

-

-

-

Receivable from collaboration partner - related party

-

-

-

-

-

-

-

5,785

2,722

-

-

-

-

-

-

-

-

Research and development tax incentive receivable

153

-

173

1,421

1,876

1,429

1,155

2,190

1,918

1,347

-

-

-

2,241

-

-

-

Receivable from collaboration partner - related party

-

-

-

-

-

-

-

-

-

-

520

-

-

-

-

-

-

Research and development tax incentive receivable

-

-

-

-

-

-

-

-

-

-

885

2,881

2,480

-

1,944

1,744

715

Prepaid expenses and other current assets

4,716

5,529

4,203

4,899

3,502

2,624

3,234

2,959

2,621

3,773

2,703

1,743

1,810

3,394

1,768

487

1,558

Total current assets

125,986

145,311

144,023

137,320

122,995

137,503

147,502

136,111

142,231

150,947

97,704

69,126

67,548

83,244

102,245

22,417

-

Property and equipment, net

1,603

1,681

1,734

1,692

1,546

861

904

912

1,001

879

945

903

641

562

564

599

609

Restricted cash - noncurrent

450

450

450

450

450

450

450

450

450

450

450

450

450

-

-

-

-

Operating lease right-of-use asset

5,780

6,042

6,295

6,539

6,779

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax asset

1,082

1,433

2,125

2,104

-

658

-

-

-

-

-

-

-

-

-

-

-

Available-for-sale securities - noncurrent

-

-

-

-

-

-

-

-

5,557

11,458

11,316

0

14,000

10,150

-

-

-

Deferred tax asset

-

-

-

-

478

-

-

-

-

-

-

-

-

-

-

-

-

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,466

-

Other assets

-

-

-

-

-

-

-

-

-

-

0

0

34

34

34

34

30

Total assets

134,901

154,917

154,627

148,105

132,248

139,472

148,856

137,473

149,239

163,734

110,415

70,479

82,673

93,990

102,843

24,516

14,845

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable

3,704

2,790

1,583

2,787

6,454

5,711

4,871

2,278

1,307

1,257

2,267

2,639

1,132

1,163

2,335

1,441

1,247

Payable to collaboration partner - related party

1,116

1,262

1,020

810

1,211

1,061

764

-

-

-

-

-

-

-

-

-

-

Payable to collaboration partner - related party

-

-

-

-

-

-

-

276

379

-

-

-

-

-

-

-

-

Accrued expenses and other payables

11,616

12,360

10,486

10,845

8,713

11,163

10,496

13,262

10,358

9,546

8,241

6,727

6,647

5,272

3,014

2,669

1,879

Deferred revenue - related party - current

18,630

17,738

16,478

17,717

7,001

8,223

7,970

13,202

21,880

31,752

-

-

-

-

-

-

-

Operating lease liability - current

1,306

1,256

1,209

1,164

1,120

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue - related party

-

-

-

-

-

-

-

-

-

-

41,739

-

-

-

-

-

-

Total current liabilities

36,372

35,406

30,776

33,323

24,499

26,158

24,101

29,018

33,924

42,555

52,247

9,366

7,779

6,435

5,349

4,110

3,126

Long-term debt, net

9,832

9,794

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue - related party - noncurrent

20,415

23,792

22,200

23,850

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability - noncurrent

5,616

5,961

6,293

6,616

6,924

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

799

797

793

694

547

332

83

-

-

-

-

-

Redeemable convertible preferred stock tranche liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,643

Redeemable convertible preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

480

Total liabilities

72,235

74,953

59,269

63,789

31,423

26,957

24,898

29,811

34,618

43,102

52,579

9,449

-

6,435

5,349

4,110

5,249

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

Redeemable convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

66,610

36,996

Stockholders’ equity:
Preferred stock, $0.00001 par value, 10,000,000 shares authorized; no shares issued and outstanding

-

-

-

-

-

-

0

0

-

-

0

0

0

0

0

-

0

Common stock, $0.00001 par value, 90,000,000 shares authorized; 27,434,705 and 27,217,649 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

-

-

-

-

-

-

0

0

-

0

0

0

0

0

0

0

0

Additional paid-in capital

300,300

297,846

295,672

268,234

255,591

253,222

250,670

225,622

223,904

222,188

156,234

154,700

153,610

152,393

150,863

158

118

Accumulated other comprehensive gain (loss)

107

-221

-154

-167

-189

-233

-103

-86

-72

-6

100

3

-22

-245

-24

-101

-102

Accumulated deficit

-237,700

-217,661

-200,160

-183,751

-154,577

-140,474

-126,609

-117,874

-109,211

-101,550

-98,498

-93,673

-78,694

-64,593

-53,345

-46,261

-27,416

Total stockholders’ equity

62,666

79,964

95,358

84,316

100,825

112,515

123,958

107,662

114,621

120,632

57,836

61,030

74,894

87,555

97,494

-46,204

-27,400

Total liabilities and stockholders’ equity

134,901

154,917

154,627

148,105

132,248

139,472

148,856

137,473

149,239

163,734

110,415

70,479

82,673

93,990

102,843

24,516

14,845